By Tarek Haykal, MD The COVID-19 pandemic has forced humanity to adjust and change numerous aspects of our daily lives; normalcy has been redefined with a lasting impact. Every socioeconomic strata and sector has been affected, including health care. But health care practitioners found versatile methods, including telemedicine, to deliver care to their patients, especially those requiring frequent surveillance.

Date: December 16, 2021

Time: 4:00 - 5:30 pm

Location: Zoom

This December, the Karmanos Health Equity Book Club will be reading the book Black Man in a White Coat: A Doctor's Reflections on Race and Medicine. We are extremely pleased to announce that we will be joined by the author, Damon Tweedy, M.D. to discuss the book and his work.

Register to join us today! The webinar is limited to 500 people, so space is limited.

Date: December 1, 2021

Time: 12:00 p.m. - 1:00 p.m.

Location: ZOOM

During this webinar, Dr. Gillespie will discuss the topic of debriefing. Specifically, she will talk about handling upsetting, disappointing, or frustrating situations with "hot debriefing", which is based on self-debriefing and emotional intelligence. We will talk about how this tool can help both as a leader with team dynamics as well as be helpful personally with unloading some of the emotional stresses related to work.

Letter of Intent Due: February 1, 2022 (Confirmed)

Phase I and II patient-centered clinical trials focus on the following priority research areas:

• Biomarkers/Molecular Markers (genomic or proteomic)
• Gene Therapy
• Histology Agnostic/Basket Trial
• Immunotherapy
• Targeted Therapies

Our focus is on the following therapeutic areas:

• New Investigational Therapies
• Novel Use or Approach
• Precision Medicine
• Integrative Medicine

Clinical trial and W/O trial are available.

Application Due: February 12, 2022

This Funding Opportunity Announcement (FOA) represents the continuation of an NCI program to facilitate the transition of investigators in mentored, non-independent cancer research positions to independent faculty cancer research positions. This goal is achieved by providing protected time through salary and research support for the initial 3 years of the first independent tenure-track faculty position, or its equivalent, beginning at the time when the candidate starts a tenure-track faculty position.